gvs 111 has been researched along with Prediabetic State in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anisina, EA; Durnev, AD; Gudasheva, TA; Ostrovskaya, RU; Yagubova, SS; Zhanataev, AK | 1 |
1 other study(ies) available for gvs 111 and Prediabetic State
Article | Year |
---|---|
Neuroprotective Dipeptide Noopept Prevents DNA Damage in Mice with Modeled Prediabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dipeptides; DNA Damage; Hyperglycemia; Insulin-Secreting Cells; Kidney; Liver; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Neuroprotective Agents; Prediabetic State; Streptozocin | 2019 |